90
Participants
Start Date
October 5, 2021
Primary Completion Date
January 30, 2022
Study Completion Date
February 1, 2022
0.15% bezaydamine hydrochloride.
0.15% bezaydamine hydrochloride was applied in oral mucosa in Patients with head and neck cancer under RT, CT treatment.
low power laser with a wavelength of 870 nm
the irradiations will be done three times a week using low power laser with a wavelength of 870 nm. The irradiation mode will be punctual and in contact, perpendicular to the oral mucosa. The power will be 60 mW, energy density of 6 J/cm2. Irradiation time will be 6 seconds per point based on the laser beam spot size of 0.55cm2
Faculty of dental medicine Al-Azhar University (Assiut branch), Asyut
Al-Azhar University
OTHER